Clinical Trial Update: Testogel® (Testosterone Gel 50mg/5g) in the Treatment of Male Hypogonadism [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Testogel (testosterone gel 50 mg/5 g) for male hypogonadism; current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism

Drugs mentioned

• Testogel (testosterone)

Snippet

Sponsor: Laboratoires Besins International | Conditions: Hypogonadism | Phase 3 | Status: UNKNOWN